Printer Friendly
The Free Library
4,656,501 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AMGEN EXPECTED TO MEET ESTIMATES.


Byline: Robert Monroe Staff Writer

THOUSAND OAKS Thousand Oaks, residential city (1990 pop. 104,352), Ventura co., S Calif., in a farm area; inc. 1964. Avocados, citrus, vegetables, strawberries, and nursery products are grown.  - A quarterly earnings report to be released today will likely show Amgen's steady ascent continuing, analysts said Tuesday.

A First Call/Thomson Financial consensus of analysts estimates the biotechnology leader will post second-quarter earnings of 27 cents per share Cents per share

The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned.
, exceeding the company's net income of 25 cents per share in the second quarter of 1999. Individual analysts are mixed on the company's potential to do better than expected.

``Tough call in the short run, but I think they'll be on target,'' said Edward Jones Edward, Eddie, or Ed Jones is the name of:

Edward Jones:
  • Edward Jones (statistician) (1856-1920), co-founder of the Dow-Jones index
  • Edward E. Jones (1927-1993), psychologist
  • Edward (Ted) G. Jones, neuroscientist
  • Edward P.
 analyst Bob Kirby.

Dennis Harp of Deutsche Bank Alex. Brown Deutsche Bank Alex. Brown is the private client services division of Deutsche Bank Securities, the U.S. corporate and investment arm of German banking colossus Deutsche Bank. It is the organization successor to the 200 year-old investment bank Alex.  believes the company will match or exceed his 26 cents-per-share earnings estimate.

Harp said the company's strong second-quarter sales will be tempered by its investments as it gears up for next year's production of at least two new drugs in addition to mainstays Epogen, an anemia medication, and cancer drug Neupogen.

``The real reason investors should be excited about Amgen is its pipeline of drugs coming to market,'' said Harp.

The company's stock finished Tuesday down $1.13 to $73.63. It peaked over the weekend at $80.44 before dipping to the $74 range as investors sought to cash in on Amgen's highest share price since splitting in November.

Kirby thinks the company has benefited from a rediscovery Noun 1. rediscovery - the act of discovering again
discovery, find, uncovering - the act of discovering something

rediscovery nredescubrimiento 
 of biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
 stocks by investors in recent weeks but added Amgen is a victim of high expectations. Any failure to meet them could send its share price tumbling.

``They have very little room to disappoint,'' Kirby said.
COPYRIGHT 2000 Daily News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Business
Publication:Daily News (Los Angeles, CA)
Date:Jul 26, 2000
Words:257
Previous Article:IN BRIEF.(Business)
Next Article:CHILDREN THROWN FROM SUSPECT'S TRUCK.(News)



Related Articles
Hitting Goal On Earnings A Necessity.(Statistical Data Included)
Analysts Downgrade Amgen Despite Good Results.(shares of Amgen Inc.)(Brief Article)
BIOTECH FIRM TRIMS FORECASTS INVESTORS PUNISH AMGEN.(Business)
AMGEN EXPECTED TO REPORT DECLINE.(Business)
AMGEN OUTLINES BOLD GROWTH PLAN.(Business)(Statistical Data Included)
STRONG AMGEN EARNINGS EXPECTED; NEWS KEEPS SHARES RISING.(Business)
AMGEN INC. SHARES DOWN DESPITE EARNINGS OUTLOOK.(Business)(Statistical Data Included)
ANALYSTS EXPECT RISE IN AMGEN EARNINGS.(Business)
Amgen has right prescription for sales of blockbuster drugs. (Up Front).
Amgen falls Ill from Medicare payment shifts.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles